Story perspectives

Revolutionary Blood Test Aims to Transform Brain Tumor Treatment

2/2/2026

47 11

Summary

Story summary

The Phenotype Analyzer Chip, developed in Australia, can assess brain tumor responses through a simple blood test.
Researchers aim to improve survival for glioblastoma, Australia's most common and aggressive brain cancer.
Dr. Richard Lobb says device could also aid in treating neurological disorders such as Alzheimer's and Parkinson's.
The device has been tested in more than 40 patients, and researchers will move to clinical trials to expand rural access.

1 of 1

Story summary

The Phenotype Analyzer Chip, developed in Australia, can assess brain tumor responses through a simple blood test.
Researchers aim to improve survival for glioblastoma, Australia's most common and aggressive brain cancer.
Dr. Richard Lobb says device could also aid in treating neurological disorders such as Alzheimer's and Parkinson's.
The device has been tested in more than 40 patients, and researchers will move to clinical trials to expand rural access.